Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Giunta

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Translational Research|December 8, 2009
Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic miceElona Rrapo, Yuyan Zhu, Jun Tian, et al.
Molecular Neurodegeneration|October 12, 2014
The role of tau protein in HIV-associated neurocognitive disordersLecia A M Brown, James Scarola, Adam J Smith, et al.
Plos One|May 15, 2008
CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activationYuyan Zhu, Huayan Hou, William V Nikolic, et al.
Drug Discovery Today|August 20, 2013
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapiesYu-Hui Liu, Fan Zeng, Ye-Ran Wang, et al.
Molecular Neurodegeneration|January 13, 2011
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)Jon Salemi, Demian F Obregon, Anthony Cobb, et al.
Journal of Neuroscience Research|May 21, 2013
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse modelShe-Qing Zhang, Demian Obregon, Jared Ehrhart, et al.
Plos One|April 25, 2014
Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND)Lecia A M Brown, Jingji Jin, Darren Ferrell, et al.
Molecular Brain|June 9, 2011
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disordersBrian Giunta, Jared Ehrhart, Demian F Obregon, et al.
Journal of Neuroimmunology|September 22, 2009
Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autismEllisa Parker-Athill, Deyan Luo, Antoinette Bailey, et al.
Brain Research|November 3, 2006
EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementiaBrian Giunta, Demian Obregon, Hauyan Hou, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Translational Research|December 8, 2009
Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic miceElona Rrapo, Yuyan Zhu, Jun Tian, et al.
Molecular Neurodegeneration|October 12, 2014
The role of tau protein in HIV-associated neurocognitive disordersLecia A M Brown, James Scarola, Adam J Smith, et al.
Plos One|May 15, 2008
CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activationYuyan Zhu, Huayan Hou, William V Nikolic, et al.
Drug Discovery Today|August 20, 2013
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapiesYu-Hui Liu, Fan Zeng, Ye-Ran Wang, et al.
Molecular Neurodegeneration|January 13, 2011
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)Jon Salemi, Demian F Obregon, Anthony Cobb, et al.
Journal of Neuroscience Research|May 21, 2013
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse modelShe-Qing Zhang, Demian Obregon, Jared Ehrhart, et al.
Plos One|April 25, 2014
Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND)Lecia A M Brown, Jingji Jin, Darren Ferrell, et al.
Molecular Brain|June 9, 2011
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disordersBrian Giunta, Jared Ehrhart, Demian F Obregon, et al.
Journal of Neuroimmunology|September 22, 2009
Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autismEllisa Parker-Athill, Deyan Luo, Antoinette Bailey, et al.
Brain Research|November 3, 2006
EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementiaBrian Giunta, Demian Obregon, Hauyan Hou, et al.
Pageof 6